Thursday - March 28, 2024
STALEVO MAY HELP MORE THAN STANDARD THERAPY FOR EARLY PARKINSON'S DISEASE
April 15, 2008
BASEL, Switzerland, April 15 -- The University of South Florida issued the following news release:

A new study in patients with early Parkinson's disease demonstrates that Stalevo (a combination of levodopa/carbidopa/entacapone) provides better symptom control and greater improvements in activities of daily living than levodopa/carbidopa, the most widely-used current therapy.

The FIRST STEP study was presented today at the American Academy of Neurology Annual Meetin . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products